As 2024 concludes, here are 6 significant scientific discoveries, including medical breakthroughs, space exploration, and ...

Psychedelic industry faced setbacks, cannabis was almost rescheduled and overdose deaths dropped — but not for all ...

There is hope for a new 5 by 3 global target of getting 5 million people on long-acting PrEP to prevent HIV by 2030.

Science magazine has chosen twice-yearly lenacapavir PrEP as its 2024 Breakthrough of the Year, recognizing it as a ...

Investors are bullish on Gilead as the stock surges on successful launches and strong financial health, offering potential ...

There's no question that the world has a trash problem. E-waste is no exception. The 2024 Global E-waste Monitor, published ...

Several giant US and international groups focused on fighting HIV and AIDS on Tuesday unveiled a plan to swiftly provide ...

Lenacapavir, a preventive HIV drug, could become accessible in low-income countries by 2026. Efforts spearheaded by global ...

By 2025, a new HIV preventive drug, lenacapavir, could be available to the world's poorest regions. The Global Fund aims to ...

A new long-acting preventive HIV drug could reach the world’s poorest countries by the end of 2025 or early 2026, a global ...